Accuracy of diffusion weighted MRI in detecting residual tumor in patients conservatively treated for cervical carcinoma.

Accuracy of diffusion weighted MRI in detecting residual tumor in patients conservatively treated for cervical carcinoma. - MRI-DWI in cervix carcinoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39623

Enrollment

120

Registered

2011-01-24

Start date

2011-02-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Recent history of cervical cancer - Patients treated with radiation therapy with curative intent, with or without concomitant chemotherapy or hyperthermia. - Age>=18 years - Informed consent

Exclusion criteria

Exclusion criteria: - Pregnancy - Contra-indications for general anesthesia - Contra-indications for MRI (incl. Claustrophobia, metal implants, renal insufficiency, etc.) - Incapacity of judgement

Design outcomes

Primary

Measure	Time frame
To determine the accuracy of MRI with DWI in detecting residual disease in patients with uterine cervical cancer treated with (chemo)radiotherapy. To determine the additional value of using DWI to a standard MRI protocol. To evaluate in the inter-reader variability in reading DWI images in the post-treatment setting.	—

Countries

Netherlands

Outcome results